SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-000976
Filing Date
2021-01-04
Accepted
2021-01-04 16:17:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d821456dsc13d.htm SC 13D 42653
  Complete submission text file 0001193125-21-000976.txt   44159
Mailing Address MORRIS CORP. CENTER I; BLDG. B; 4TH FLR. 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address
COLES N ANTHONY (Filed by) CIK: 0001197018 (see all company filings)

Type: SC 13D

Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Subject) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89403 | Film No.: 21501988
SIC: 2834 Pharmaceutical Preparations